247 related articles for article (PubMed ID: 9342358)
1. Incomplete penetrance of familial retinoblastoma linked to germ-line mutations that result in partial loss of RB function.
Otterson GA; Chen Wd; Coxon AB; Khleif SN; Kaye FJ
Proc Natl Acad Sci U S A; 1997 Oct; 94(22):12036-40. PubMed ID: 9342358
[TBL] [Abstract][Full Text] [Related]
2. Temperature-sensitive RB mutations linked to incomplete penetrance of familial retinoblastoma in 12 families.
Otterson GA; Modi S; Nguyen K; Coxon AB; Kaye FJ
Am J Hum Genet; 1999 Oct; 65(4):1040-6. PubMed ID: 10486322
[TBL] [Abstract][Full Text] [Related]
3. Partial inactivation of the RB product in a family with incomplete penetrance of familial retinoblastoma and benign retinal tumors.
Kratzke RA; Otterson GA; Hogg A; Coxon AB; Geradts J; Cowell JK; Kaye FJ
Oncogene; 1994 May; 9(5):1321-6. PubMed ID: 8152792
[TBL] [Abstract][Full Text] [Related]
4. Growth suppression by an E2F-binding-defective retinoblastoma protein (RB): contribution from the RB C pocket.
Whitaker LL; Su H; Baskaran R; Knudsen ES; Wang JY
Mol Cell Biol; 1998 Jul; 18(7):4032-42. PubMed ID: 9632788
[TBL] [Abstract][Full Text] [Related]
5. A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability.
Woitach JT; Zhang M; Niu CH; Thorgeirsson SS
Nat Genet; 1998 Aug; 19(4):371-4. PubMed ID: 9697699
[TBL] [Abstract][Full Text] [Related]
6. Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma.
Bremner R; Du DC; Connolly-Wilson MJ; Bridge P; Ahmad KF; Mostachfi H; Rushlow D; Dunn JM; Gallie BL
Am J Hum Genet; 1997 Sep; 61(3):556-70. PubMed ID: 9326321
[TBL] [Abstract][Full Text] [Related]
7. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites.
Sellers WR; Rodgers JW; Kaelin WG
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11544-8. PubMed ID: 8524800
[TBL] [Abstract][Full Text] [Related]
8. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
Li JM; Hu PP; Shen X; Yu Y; Wang XF
Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
[TBL] [Abstract][Full Text] [Related]
9. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product.
Flemington EK; Speck SH; Kaelin WG
Proc Natl Acad Sci U S A; 1993 Aug; 90(15):6914-8. PubMed ID: 8346196
[TBL] [Abstract][Full Text] [Related]
10. Disruption of retinoblastoma protein function by coexpression of its C pocket fragment.
Welch PJ; Wang JY
Genes Dev; 1995 Jan; 9(1):31-46. PubMed ID: 7828850
[TBL] [Abstract][Full Text] [Related]
11. Retinoblastoma-repression of E2F-dependent transcription depends on the ability of the retinoblastoma protein to interact with E2F and is abrogated by the adenovirus E1A oncoprotein.
Arroyo M; Raychaudhuri P
Nucleic Acids Res; 1992 Nov; 20(22):5947-54. PubMed ID: 1461728
[TBL] [Abstract][Full Text] [Related]
12. Neural precursor cells differentiating in the absence of Rb exhibit delayed terminal mitosis and deregulated E2F 1 and 3 activity.
Callaghan DA; Dong L; Callaghan SM; Hou YX; Dagnino L; Slack RS
Dev Biol; 1999 Mar; 207(2):257-70. PubMed ID: 10068462
[TBL] [Abstract][Full Text] [Related]
13. Regulation of BRCA1 expression by the Rb-E2F pathway.
Wang A; Schneider-Broussard R; Kumar AP; MacLeod MC; Johnson DG
J Biol Chem; 2000 Feb; 275(6):4532-6. PubMed ID: 10660629
[TBL] [Abstract][Full Text] [Related]
14. Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis.
Shan B; Durfee T; Lee WH
Proc Natl Acad Sci U S A; 1996 Jan; 93(2):679-84. PubMed ID: 8570615
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases.
Wang S; Nath N; Minden A; Chellappan S
EMBO J; 1999 Mar; 18(6):1559-70. PubMed ID: 10075927
[TBL] [Abstract][Full Text] [Related]
16. Transient accumulation of retinoblastoma/E2F-1 protein complexes correlates with the onset of neuronal differentiation in the developing quail neural retina.
Kastner A; Espanel X; Brun G
Cell Growth Differ; 1998 Oct; 9(10):857-67. PubMed ID: 9790497
[TBL] [Abstract][Full Text] [Related]
17. E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction.
Hsieh JK; Fredersdorf S; Kouzarides T; Martin K; Lu X
Genes Dev; 1997 Jul; 11(14):1840-52. PubMed ID: 9242491
[TBL] [Abstract][Full Text] [Related]
18. Differential specificity for binding of retinoblastoma binding protein 2 to RB, p107, and TATA-binding protein.
Kim YW; Otterson GA; Kratzke RA; Coxon AB; Kaye FJ
Mol Cell Biol; 1994 Nov; 14(11):7256-64. PubMed ID: 7935440
[TBL] [Abstract][Full Text] [Related]
19. Activation of a retinoblastoma-protein-dependent pathway by sphingosine.
Dbaibo GS; Wolff RA; Obeid LM; Hannun YA
Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):453-9. PubMed ID: 7654183
[TBL] [Abstract][Full Text] [Related]
20. Engineered mutants of pRB with improved growth suppression potential.
Antelman D; Perry S; Hollingsworth R; Gregory RJ; Driscoll B; Fung YK; Bookstein R
Oncogene; 1997 Dec; 15(23):2855-66. PubMed ID: 9419977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]